Author
J. T. Seykora
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2020-2023 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 16 mutual co-author links5 papers
Recent·Most cited
Keratinocyte desmosomal cadherin Desmoglein 1 as a mediator and target of paracrine signaling in the melanoma niche
H. E. Burks, J. L. Pokorny, J. L. Koetsier, Q. R. Roth-Carter, C. R. Arnette, P. Gerami, J. T. Seykora, J. L. Johnson, K. J. Green
The paper shows melanoma cells exploit keratinocyte Dsg1 reduction via paracrine signaling to enhance tumor spread through CXCL1/CXCR2 and Snai2/Grhl1 pathways.
bioRxiv · Dec 1, 2022 · PreprintCancer Biology
H3K36M provokes cellular plasticity to drive aberrant glandular formation and squamous carcinogenesis
E. K. Ko, A. Anderson, J. Zou, S. Huang, S. Cho, F. Alawi, S. Prouty, V. Lee, K. Ge, J. T. Seykora, B. C. Capell
This study shows that H3K36M oncohistone disrupts epithelial differentiation, increases cellular plasticity, and drives squamous carcinogenesis by altering histone modifications.
bioRxiv · Aug 19, 2022 · PreprintCancer Biology
MLL4 is a critical mediator of differentiation and ferroptosis in the epidermis
S. Egolf, J. Zou, A. Anderson, Y. Aubert, K. Ge, J. T. Seykora, B. C. Capell
This study identifies MLL4's role in promoting epidermal differentiation and ferroptosis, linking it to tumor suppression and skin homeostasis.
bioRxiv · May 3, 2021 · PreprintCancer Biology
ZIP9 is a Druggable Determinant of Sex Differences in Melanoma
C. Aguirre-Portoles, R. Payne, A. Trautz, J. K. Foskett, C. A. Natale, J. T. Seykora, T. W. Ridky
The paper identifies ZIP9 as a target of testosterone in melanoma and shows that androgen receptor inhibitors can block ZIP9 to suppress melanoma growth in males.
bioRxiv · Mar 12, 2020Cancer Biology